Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma - Top-Institutions - MDSpire

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

  • By

  • Hao Su

  • Xinyu Zhao

  • Xiaoyu Qin

  • Xu Zhou

  • Mianli Li

  • Lijun Tian

  • June 19, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

  • by Hao Su, Xinyu Zhao, Xiaoyu Qin, Xu Zhou, Mianli Li, Lijun Tian

  • June 19, 2026

Related Content

Epilepsy characteristics and outcomes in patients with pleomorphic xanthoastrocytomas

A deep learning-based radiomic nomogram derived from visceral fat for early prediction of gastrointestinal stromal tumor risk grade

Association between metabolic syndrome components and the risk of malignant neoplasms of the brain: a nationwide cohort study